RedHill Biopharma Ltd. RDHL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.16M | 5.16M | 3.97M | 3.97M | 2.87M |
| Total Receivables | -- | -- | 1.70M | 1.70M | 5.35M |
| Inventory | -- | -- | -- | -- | 3.17M |
| Prepaid Expenses | 3.42M | 3.42M | 778.00K | 778.00K | 1.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 78.00K | 78.00K | 160.00K |
| Total Current Assets | 8.57M | 8.57M | 6.53M | 6.53M | 12.56M |
|
|
|||||
| Total Current Assets | 8.57M | 8.57M | 6.53M | 6.53M | 12.56M |
| Net Property, Plant & Equipment | 979.00K | 979.00K | 1.11M | 1.11M | 289.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.29M | 5.29M | 5.29M | 5.29M | 5.53M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 309.00K | 309.00K | 370.00K | 370.00K | -- |
| Total Assets | 26.27M | 26.27M | 25.35M | 25.35M | 18.38M |
|
|
|||||
| Total Accounts Payable | 584.00K | 584.00K | 731.00K | 731.00K | 835.00K |
| Total Accrued Expenses | 17.68M | 17.68M | 9.80M | 9.80M | 20.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 216.00K | 216.00K | 170.00K | 170.00K | 214.00K |
| Total Finance Division Other Current Liabilities | 7.08M | 7.08M | 8.52M | 8.52M | 1.08M |
| Total Other Current Liabilities | 7.08M | 7.08M | 8.52M | 8.52M | 1.08M |
| Total Current Liabilities | 25.56M | 25.56M | 19.22M | 19.22M | 22.29M |
|
|
|||||
| Total Current Liabilities | 25.56M | 25.56M | 19.22M | 19.22M | 22.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 859.00K | 859.00K | 900.00K | 900.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 933.00K | 933.00K | 956.00K | 956.00K | 500.00K |
| Total Liabilities | 27.35M | 27.35M | 21.08M | 21.08M | 22.79M |
|
|
|||||
| Common Stock & APIC | 418.09M | 418.09M | 418.02M | 418.02M | 413.71M |
| Retained Earnings | -419.16M | -419.16M | -413.76M | -413.76M | -418.12M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.08M | -1.08M | 4.27M | 4.27M | -4.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.08M | -1.08M | 4.27M | 4.27M | -4.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.08M | -1.08M | 4.27M | 4.27M | -4.41M |
|
|
|||||